For patients entering hospitals and long term care facilities, MRSA can become a larger health threat than their admitting diagnosis. MRSA poses a significant threat to elderly and immunodeficient patients and has become a challenge to the health care providers concerned with treating and eliminating the spread of this infection.

Recognising this need, O' Flynn Medical has introduced Silver3 Antimicrobial Fabric, a revolutionary technology that will redefine infection control and pressure ulcer management.

MRSA QUICK FACTS:

• Silver3 kills 99.9% of MRSA bacteria
• MRSA infections can increase length of stay by over 400%
• Patients with MRSA infections have significantly higher mortality than non-infected patients
• Silver3 enhances the effectiveness of cleaning regimens by terminating residual bacteria that may have escaped the cleaning process
• Silver3 helps manage liability risk by reducing the likelihood of cross-contamination between patients
• Silver3 has the same immersion, breathability, moisture-proof, and comfort characteristics of a pressure redistribution surface cover
• Silver3 has been tested to internationally recognized standards for patient safety
• Silver3 will not discolour the patient's skin or linens
• Silver3 is environmentally friendly as it does not leach
• Silver3 is a unique technology developed through years of research by two leaders in healthcare